Multidimensional Proteomic Approach of Endothelial Progenitors Demonstrate Expression of KDR Restricted to CD19 Cells.


Journal

Stem cell reviews and reports
ISSN: 2629-3277
Titre abrégé: Stem Cell Rev Rep
Pays: United States
ID NLM: 101752767

Informations de publication

Date de publication:
04 2021
Historique:
accepted: 18 10 2020
pubmed: 19 11 2020
medline: 20 4 2021
entrez: 18 11 2020
Statut: ppublish

Résumé

Endothelial progenitor cells (EPCs) are involved in vasculogenesis and cardiovascular diseases. However, the phenotype of circulating EPCs remains elusive but they are more often described as CD34

Identifiants

pubmed: 33205351
doi: 10.1007/s12015-020-10062-1
pii: 10.1007/s12015-020-10062-1
pmc: PMC7670993
doi:

Substances chimiques

Antigens, CD19 0
CD19 molecule, human 0
KDR protein, human EC 2.7.10.1
Vascular Endothelial Growth Factor Receptor-2 EC 2.7.10.1

Types de publication

Clinical Trial Journal Article Multicenter Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

639-651

Subventions

Organisme : ANR and Fondation de France
ID : SARCODO
Organisme : AP-HP
ID : mécénat crise COVID-19 - GHU APHP.CUP

Références

Lancet. 2020 Feb 22;395(10224):565-574
pubmed: 32007145
Ann Intensive Care. 2020 Jul 16;10(1):95
pubmed: 32676824
Lancet. 2020 May 2;395(10234):1417-1418
pubmed: 32325026
J Allergy Clin Immunol. 2020 Jul;146(1):211-213.e4
pubmed: 32333914
Am J Physiol Heart Circ Physiol. 2003 Sep;285(3):H931-7
pubmed: 12915384
Cell Rep. 2015 Mar 17;10(10):1708-1721
pubmed: 25772358
Nat Med. 2013 Oct;19(10):1273-80
pubmed: 24037091
Respir Res. 2020 Jul 28;21(1):198
pubmed: 32723327
J Am Coll Cardiol. 2017 Jul 18;70(3):404-406
pubmed: 28705324
J Thromb Haemost. 2019 Jul;17(7):1190-1194
pubmed: 31119878
Stem Cell Rev Rep. 2021 Apr;17(2):694-699
pubmed: 32970229
J Heart Lung Transplant. 2018 Jan;37(1):33-37
pubmed: 28986001
Circ Res. 2016 Jun 10;118(12):1930-9
pubmed: 27073015
Stem Cells Int. 2016;2016:7162160
pubmed: 28074098
Cell. 2014 Apr 24;157(3):714-25
pubmed: 24766814
Angiogenesis. 2013 Jan;16(1):147-57
pubmed: 22983452
Cytotherapy. 2014 Feb;16(2):213-24
pubmed: 24280239
Blood. 2018 Apr 5;131(14):1617-1621
pubmed: 29439955
N Engl J Med. 2020 Jul 9;383(2):120-128
pubmed: 32437596
N Engl J Med. 2005 Sep 8;353(10):999-1007
pubmed: 16148285
J Thromb Haemost. 2020 Sep;18(9):2391-2399
pubmed: 32558198
Arterioscler Thromb Vasc Biol. 2012 Apr;32(4):1045-53
pubmed: 22282356
Nat Biotechnol. 2018 Dec 03;:
pubmed: 30531897
Nat Biotechnol. 2011 Oct 02;29(10):886-91
pubmed: 21964415
Stem Cell Rev Rep. 2021 Feb;17(1):4-8
pubmed: 32399806
Circ Res. 2017 Jan 6;120(1):166-178
pubmed: 28057792
Trends Immunol. 2012 Jul;33(7):323-32
pubmed: 22476049
Cytometry A. 2017 Mar;91(3):254-260
pubmed: 28248454
Angiogenesis. 2020 Nov;23(4):611-620
pubmed: 32458111
Thromb Haemost. 2015 May;113(5):1084-94
pubmed: 25608764
Physiol Rev. 2013 Oct;93(4):1743-802
pubmed: 24137021
Science. 1999 Sep 3;285(5433):1553-8
pubmed: 10477517

Auteurs

Coralie L Guerin (CL)

Innovative Therapies in Haemostasis, INSERM, Université de Paris, F-75006, Paris, France.
Cytometry Platform, Institut Curie, F-75006, Paris, France.
Department of Infection and Immunity, Luxembourg Institute of Health, Strassen, Luxembourg.

Léa Guyonnet (L)

Innovative Therapies in Haemostasis, INSERM, Université de Paris, F-75006, Paris, France.
Cytometry Platform, Institut Curie, F-75006, Paris, France.
Department of Infection and Immunity, Luxembourg Institute of Health, Strassen, Luxembourg.

Guillaume Goudot (G)

Vascular Medicine Department and Biosurgical Research Laboratory (Carpentier Foundation), AH-HP, Georges Pompidou European Hospital, Université de Paris, F-75015, Paris, France.

Dominique Revets (D)

Department of Infection and Immunity, Luxembourg Institute of Health, Strassen, Luxembourg.

Maria Konstantinou (M)

Department of Infection and Immunity, Luxembourg Institute of Health, Strassen, Luxembourg.

Anna Chipont (A)

Department of Infection and Immunity, Luxembourg Institute of Health, Strassen, Luxembourg.

Richard Chocron (R)

PARCC, INSERM, Université de Paris, F-75006, Paris, France.
Emergency Department, AH-HP, Georges Pompidou European Hospital, F-75015, Paris, France.

Adeline Blandinieres (A)

Innovative Therapies in Haemostasis, INSERM, Université de Paris, F-75006, Paris, France.
Hematology Department and Biosurgical Research Laboratory (Carpentier Foundation), AH-HP, Georges Pompidou European Hospital, F-75015, Paris, France.

Lina Khider (L)

Vascular Medicine Department and Biosurgical Research Laboratory (Carpentier Foundation), AH-HP, Georges Pompidou European Hospital, Université de Paris, F-75015, Paris, France.

Jeanne Rancic (J)

Innovative Therapies in Haemostasis, INSERM, Université de Paris, F-75006, Paris, France.
Biosurgical Research Laboratory (Carpentier Foundation), AH-HP, Georges Pompidou European Hospital, F-75015, Paris, France.

Christophe Peronino (C)

Innovative Therapies in Haemostasis, INSERM, Université de Paris, F-75006, Paris, France.
Hematology Department and Biosurgical Research Laboratory (Carpentier Foundation), AH-HP, Georges Pompidou European Hospital, F-75015, Paris, France.

Benjamin Debuc (B)

Innovative Therapies in Haemostasis, INSERM, Université de Paris, F-75006, Paris, France.
Plastic Surgery Department, AH-HP, Georges Pompidou European Hospital, F-75015, Paris, France.

Audrey Cras (A)

Innovative Therapies in Haemostasis, INSERM, Université de Paris, F-75006, Paris, France.
Cell therapy Unit, AP-HP, Saint Louis Hospital, F-75010, Paris, France.

Camille Knosp (C)

PARCC, INSERM, Université de Paris, F-75006, Paris, France.

Christian Latremouille (C)

Innovative Therapies in Haemostasis, INSERM, Université de Paris, F-75006, Paris, France.
Cardiovascular Surgery Department and Biosurgical Research Laboratory (Carpentier Foundation) AP-HP, Georges Pompidou European Hospital, F-75015, Paris, France.

Antoine Capel (A)

Carmat SA, Vélizy-Villacoublay, France.

Markus Ollert (M)

Department of Infection and Immunity, Luxembourg Institute of Health, Strassen, Luxembourg.

Jean-Luc Diehl (JL)

Innovative Therapies in Haemostasis, INSERM, Université de Paris, F-75006, Paris, France.
Biosurgical Research Laboratory (Carpentier Foundation), AH-HP, Georges Pompidou European Hospital, F-75015, Paris, France.
Intensive Care Department and Biosurgical Research Laboratory (Carpentier Foundation), AH-HP, Georges Pompidou European Hospital, F-75015, Paris, France.

Piet Jansen (P)

Carmat SA, Vélizy-Villacoublay, France.

Benjamin Planquette (B)

Innovative Therapies in Haemostasis, INSERM, Université de Paris, F-75006, Paris, France.
Biosurgical Research Laboratory (Carpentier Foundation), AH-HP, Georges Pompidou European Hospital, F-75015, Paris, France.
Respiratory Medicine department and Biosurgical Research Laboratory (Carpentier Foundation), AH-HP, Georges Pompidou European Hospital, F-75015, Paris, France.

Olivier Sanchez (O)

Innovative Therapies in Haemostasis, INSERM, Université de Paris, F-75006, Paris, France.
Biosurgical Research Laboratory (Carpentier Foundation), AH-HP, Georges Pompidou European Hospital, F-75015, Paris, France.
Respiratory Medicine department and Biosurgical Research Laboratory (Carpentier Foundation), AH-HP, Georges Pompidou European Hospital, F-75015, Paris, France.

Pascale Gaussem (P)

Innovative Therapies in Haemostasis, INSERM, Université de Paris, F-75006, Paris, France.
Hematology Department, AH-HP, Georges Pompidou European Hospital, F-75015, Paris, France.

Tristan Mirault (T)

PARCC, INSERM, Université de Paris, F-75006, Paris, France.
Vascular Medicine department, AH-HP, Georges Pompidou European Hospital, F-75015, Paris, France.

Alain Carpentier (A)

Innovative Therapies in Haemostasis, INSERM, Université de Paris, F-75006, Paris, France.
Cardiovascular Surgery Department and Biosurgical Research Laboratory (Carpentier Foundation) AP-HP, Georges Pompidou European Hospital, F-75015, Paris, France.

Nicolas Gendron (N)

Innovative Therapies in Haemostasis, INSERM, Université de Paris, F-75006, Paris, France.
Hematology Department and Biosurgical Research Laboratory (Carpentier Foundation), AH-HP, Georges Pompidou European Hospital, F-75015, Paris, France.

David M Smadja (DM)

Innovative Therapies in Haemostasis, INSERM, Université de Paris, F-75006, Paris, France. david.smadja@aphp.fr.
Hematology Department and Biosurgical Research Laboratory (Carpentier Foundation), AH-HP, Georges Pompidou European Hospital, F-75015, Paris, France. david.smadja@aphp.fr.
European Hospital Georges Pompidou, Inserm UMR-S 1140, 20 rue Leblanc, 75015, Paris, France. david.smadja@aphp.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH